Insights

Global reach One stop service across Europe and Asia, with ISO certified quality and information security systems, presenting a unified outsourcing model for clinical development, registration, and post-marketing services that can streamline vendor management for multinational pharma and biotech sponsors.

Full service offering Comprehensive capabilities from consulting and preclinical through clinical trials, regulatory support, pharmacovigilance, and post-marketing surveillance, enabling cross-sell of end-to-end drug development services to clients seeking integrated solutions.

Integrated IT edge Proprietary clinical IT stack including eTMF/eISF, ePRO, EDC/eSource, and CTMS modules that speed trial execution and improve data integrity, a compelling differentiator for sponsors aiming to reduce cycle times and compliance risk.

Regulatory readiness Experience supporting registration strategy, regulatory submissions, and post-market activities across a broad list of jurisdictions, appealing to sponsors pursuing rapid approvals in Europe, Asia, and emerging markets.

Strategic growth fit Mid-sized scale with 51-200 employees and revenues in the multi-billion range signals capacity for larger programs while maintaining agility, making Smooth Drug Development an attractive partner for sponsors seeking reliable execution with flexible resourcing.

Similar companies to Smooth Drug Development, next generation e-CRO in Europe and Asia

Smooth Drug Development, next generation e-CRO in Europe and Asia Tech Stack

Smooth Drug Development, next generation e-CRO in Europe and Asia uses 8 technology products and services including Cloudflare, Google Workspace, Microsoft 365, and more. Explore Smooth Drug Development, next generation e-CRO in Europe and Asia's tech stack below.

  • Cloudflare
    Content Management System
  • jQuery UI
    Javascript Libraries
  • PWA
    Miscellaneous
  • HSTS
    Security
  • Google Analytics
    Web Analytics
  • Nginx
    Web Servers

Smooth Drug Development, next generation e-CRO in Europe and Asia's Email Address Formats

Smooth Drug Development, next generation e-CRO in Europe and Asia uses at least 3 email formats:
Smooth Drug Development, next generation e-CRO in Europe and Asia Email FormatsExamplePercentage
Last@smoothdd.comDoe@smoothdd.com
78%
First@smoothdd.comJohn@smoothdd.com
11%
FLast@smoothdd.comJDoe@smoothdd.com
11%

Frequently Asked Questions

What is Smooth Drug Development, next generation e-CRO in Europe and Asia's official website and social media links?

Minus sign iconPlus sign icon
Smooth Drug Development, next generation e-CRO in Europe and Asia's official website is smoothdd.com and has social profiles on LinkedIn.

How much revenue does Smooth Drug Development, next generation e-CRO in Europe and Asia generate?

Minus sign iconPlus sign icon
As of August 2026, Smooth Drug Development, next generation e-CRO in Europe and Asia's annual revenue is estimated to be $1B - $10B.

What is Smooth Drug Development, next generation e-CRO in Europe and Asia's SIC code and NAICS code?

Minus sign iconPlus sign icon
Smooth Drug Development, next generation e-CRO in Europe and Asia's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Smooth Drug Development, next generation e-CRO in Europe and Asia have currently?

Minus sign iconPlus sign icon
As of August 2026, Smooth Drug Development, next generation e-CRO in Europe and Asia has approximately 62 employees across 4 continents, including Asia, North America and Europe. Key team members include Ceo: D. M., Chief Operating Officer: K. A. and Head Of It Department: D. F. Explore Smooth Drug Development, next generation e-CRO in Europe and Asia's employee directory with LeadIQ.

What industry does Smooth Drug Development, next generation e-CRO in Europe and Asia belong to?

Minus sign iconPlus sign icon
Smooth Drug Development, next generation e-CRO in Europe and Asia operates in the Biotechnology Research industry.

What technology does Smooth Drug Development, next generation e-CRO in Europe and Asia use?

Minus sign iconPlus sign icon
Smooth Drug Development, next generation e-CRO in Europe and Asia's tech stack includes Cloudflare, Google Workspace, Microsoft 365, jQuery UI, PWA, HSTS, Google Analytics and Nginx.

What is Smooth Drug Development, next generation e-CRO in Europe and Asia's email format?

Minus sign iconPlus sign icon
Smooth Drug Development, next generation e-CRO in Europe and Asia's email format typically follows the pattern of Last@smoothdd.com. Find more Smooth Drug Development, next generation e-CRO in Europe and Asia email formats with LeadIQ.

When was Smooth Drug Development, next generation e-CRO in Europe and Asia founded?

Minus sign iconPlus sign icon
Smooth Drug Development, next generation e-CRO in Europe and Asia was founded in 2008.
Smooth Drug Development, next generation e-CRO in Europe and Asia logo

Smooth Drug Development, next generation e-CRO in Europe and Asia

Biotechnology ResearchDelaware, United States51-200 Employees

Smooth Drug Development is a mid-sized biotechnology research company headquartered in Wilmington, Delaware. It provides a full spectrum of clinical trial, regulatory, and post-marketing services, spanning consulting, registration strategy, clinical study execution, and pharmacovigilance across Europe and Asia. Its geographic reach includes the EAEA Region and Europe, with operations in Latvia, Lithuania, Estonia, Serbia, Slovakia, Hungary, Germany, Spain, Türkiye, India, Pakistan, and China.

The firm promotes a one-stop service model, coordinating activities from planning to product registration under a professional team and adhering to ISO 9001:2015 for vendor management. Its clients include leading pharmaceutical, biotech, and R&D organizations across Europe, the United States, the CIS, and the Asia-Pacific region, and the company maintains ISO certifications for quality, information security, and business continuity.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
51-200

Section iconFunding & Financials

  • $1B - $10B

    Smooth Drug Development, next generation e-CRO in Europe and Asia's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.